Post by NUM Study Network
757 followers
๐ก๐จ๐ ๐ฆ๐๐๐ฑ๐ ๐ก๐ฒ๐๐๐ผ๐ฟ๐ธ ๐ถ๐ป๐๐ถ๐๐ฒ๐ฑ ๐ฏ๐ ๐ง๐ ๐ ๐ฒ.๐ฉ. ๐ฎ๐ป๐ฑ ๐๐๐ฆ๐ก ๐ We were given the opportunity by TMF e. V. and KKS Netzwerk to participate in today's meeting of their work group โClinical Trialsโ(AG Klinische Studien), in order to present the #NUMStudyNetwork. ๐ Our managing director Dr. Ramsia Geisler gave a talk on the mission, structure and work flows of the #NUMStudyNetwork and the Specialty Network Infectious Diseases (#SNID), and was joined to facilitate the follow-up discussion by Jรถrg Janne Vehreschild. The thematic session was complemented by Sebastian Klammt's input on the collaboration between the KKS-Netzwerk e. V. and the NUM Study Network, as well as by Sabine Hanร information on the #NUKLEUS project of Netzwerk Universitรคtsmedizin (NUM). ๐กThe programm also featured updates on legal issues concerning clinical trials (Sebastian Klammt), as well as reports from the work group โEthics Commission" (Arbeitskreis Medizinischer Ethik-Kommissionen) (Georg Schmidt), the #KKSN (Sebastian Klammt) and the TMF e. V. ( Sebastian Claudius Semler). Many thanks ๐to TMF e.V. and KKSN for inviting us!๐ค #NUMStudyNetwork #NUM #BMFTR #SNID Dr. Anna Finzel